Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ken Heebner’s Latest Stock Picks

Capital Growth Management’s fourth play was in home appliance manufacturing giant Whirlpool, Inc. (NYSE:WHR). The company has high hopes for 2013, as evidenced by their positive outlook outlined in their last earnings release. Whirlpool is anticipating larger margins, expansion into new markets, new products, and more streamlined operations for the next year. With impressive earnings per share of 6.14 and a low P/E growth ratio, existing valuations are low and they could improve further if their performance projections are correct.

Finally, the largest automotive retailer AutoNation (NYSE:AN) rounds out this list of new positions on his 13F filing and stands as his second new auto play. The stock posted consistently positive earnings last year, and they recently recorded a 15% increase in year-over-year sales last December. With such large operations, AN should continue to be a steady hitter in automotive sales; positive quarterly revenue and earnings growth support this. Perhaps Heebner is hoping for repeat 20%+ growth in the price per share for this year?

Disclosure: I do not own shares of any stocks mentioned in this article.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!